Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 26, 2018
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
Fri, February 23, 2018
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
M. Ian Somaiya Maintained (BMRN) at Buy with Increased Target to $125 on, Feb 23rd, 2018
M. Ian Somaiya of BMO Capital, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $119 to $125 on, Feb 23rd, 2018.
M. has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with M.'s Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with M.
- Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $129 on, Wednesday, January 24th, 2018
- Liana Moussatos of "Wedbush" Upgraded from Hold to Buy on, Thursday, December 14th, 2017
